ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...

New data demonstrated that long-acting cabotegravir was preferable to daily dolutegravir/lamivudine in treatment-naive people living with HIV.

Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or even know they're an option. It's called pre-exposure prophylaxis ...

HIV treatment as prevention can help you stay healthy and cancel out chances of transmitting the virus through sex. Learn how it works and who benefits.

That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that prevents infection by the HIV virus.

The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to HIV-prevention infrastructure in the U.S.

You can keep your HIV viral load very low if you take your meds as prescribed. How do you remember to take your pills at the right time throughout the day? Find out the tips and tricks that really ...

Doctors treating a baby born with HIV have given the infant a clean bill of health after dosing the tot with a controversial cocktail of drugs.

The researchers plan to continue testing their work with medications used in combination therapies along with lamivudine, as most of these treatments involve a cocktail of two or more drugs. Because ...

Later this month, the Food and Drug Administration is widely expected to approve a groundbreaking twice-yearly injection to prevent HIV—a milestone in the decadeslong fight against a once ...

A new UVA study finds that HIV drugs like NRTIs may reduce Alzheimer's risk by 10% annually, suggesting potential for repurposing in dementia prevention.

In newly released data, lenacapavir, given via a twice-yearly injection, has shown remarkable effectiveness at eliminating HIV transmission during sexual contact. But its cost could be an issue.